Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer.

Clinical colorectal cancer - 1 Sept 2017

Rajput Ashwani, Bocklage Thèrése, Greenbaum Alissa, Lee Ji-Hyun, Ness Scott A

Abstract excerpt

BACKGROUND: Colorectal cancer is a leading cause of cancer-related mortality, has a very broad mutational spectrum, and there is no clinically available biomarker that can predict which patients with stage II or stage III colorectal cancer will develop metastatic disease. PATIENTS AND METHODS: We used a targeted next-generation sequencing approach to analyze the mutational spectra in stage II and III colon cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to Colorectal Cancer Treatments and Studies

Share to DNA Mutational Analysis

Share to Genetic factors in colorectal cancer

Share to Neoplasm Invasiveness

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 28073683
DOI: 10.1016/j.clcc.2016.11.004
PMCID: PMC5441963

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer.PMID 28073683Read ↗

Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.Semantic proximity Read ↗

Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?Semantic proximity Read ↗

Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.Semantic proximity Read ↗

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical ImplicationsSemantic proximity Read ↗

Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.Semantic proximity Read ↗

Intra-tumor genetic heterogeneity in rectal cancer.Semantic proximity Read ↗

Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal CancersSemantic proximity Read ↗

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.Semantic proximity Read ↗

Mutant allele tumor heterogeneity (MATH) and head and neck squamous cell carcinoma.Semantic proximity Read ↗

Mutational analysis and clinical correlation of metastatic colorectal cancer.Semantic proximity Read ↗

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung AdenocarcinomaSemantic proximity Read ↗

Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.